Abstract
Charcot–Marie–Tooth disease (CMT) is characterised by great variability of genetic subtypes. This study aimed to assess the genetic subtypes of CMT disease in the Sardinian population. Genetic screening was performed for CMT cases (CMT1, CMT2, and hereditary neuropathy with susceptibility to pressure palsies [HNPP]). A total of 1,043 subjects (119 index cases) were evaluated. In CMT1 index cases (69/119; 58%), PMP22 duplication at 17p11.2 was the most frequent genetic diagnosis (60/69; 87%), followed by mutations in the GJB1 gene (5/69; 7.2%), in the SH3TC2 gene (3/69; 4.4%) and PMP22 Gly107Val point mutation (1/69; 1.4%). The CMT2 group (24/119; 20.1%) comprised 10/24 (41.6%) patients carrying MPZ gene Ser44Phe mutation, 6/24 (25%) with mutations in MFN2 and HSPB1, and 1/24 (4.2%) in GJB1 and LRSAM1. In the HNPP group (26/119; 21.9%), the majority of patients reported the PMP22 deletion (25/26; 96.2%). Further studies are needed to comprehend the overall picture of the disease in Mediterranean area.
Similar content being viewed by others
References
Inherited Peripheral Neuropathies Mutation Database. http://www.molgen.ua.ac.be/cmtmutations/Mutations/Default.cfm
Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN (2003) Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 21(6):577–581
Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O’Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Berghout J, Cooper DN, Deflaux N, DePristo M, Do R, Flannick J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki MI, Moonshine AL, Natarajan P, Orozco L, Peloso GM, Poplin R, Rivas MA, Ruano-Rubio V, Rose SA, Ruderfer DM, Shakir K, Stenson PD, Stevens C, Thomas BP, Tiao G, Tusie-Luna MT, Weisburd B, Won HH, Yu D, Altshuler DM, Ardissino D, Boehnke M, Danesh J, Donnelly S, Elosua R, Florez JC, Gabriel SB, Getz G, Glatt SJ, Hultman CM, Kathiresan S, Laakso M, McCarroll S, McCarthy MI, McGovern D, McPherson R, Neale BM, Palotie A, Purcell SM, Saleheen D, Scharf JM, Sklar P, Sullivan PF, Tuomilehto J, Tsuang MT, Watkins HC, Wilson JG, Daly MJ, MacArthur DG, Exome Aggregation Consortium (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536(7616):285–291
Barreto LC, Oliveira FS, Nunes PS, de França Costa IM, Garcez CA, Goes GM et al (2016) Epidemiologic study of Charcot–Marie–Tooth disease: a systematic review. Neuroepidemiology 46(3):157–165
Dyck PJ, Lambert EH (1968) Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 18:603–618
Manganelli F, Pisciotta C, Dubbioso R, Maruotti V, Iodice R, Notturno F et al (2013) Electrophysiological comparison between males and females in HNPP. Neurol Sci. 34(8):1429–1432
Timmerman V, Strickland AV, Züchner S (2014) Genetics of Charcot–Marie–Tooth (CMT) disease within the frame of the human genome project success. Genes (Basel) 5(1):13–32
Boerkoel CF, Takashima H, Garcia CA, Olney RK, Johnson J, Berry K et al (2002) Charcot–Marie–Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol 51(2):190–201
Sivera R, Sevilla T, Vílchez JJ, Martínez-Rubio D, Chumillas MJ, Vázquez JF et al (2013) Charcot–Marie–Tooth disease: genetic and clinical spectrum in a Spanish clinical series. Neurology 81(18):1617–1625
Murphy SM, Laura M, Fawcett K, Pandraud A, Liu YT, Davidson GL et al (2012) Charcot–Marie–Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry 83(7):706–710
Gess B, Schirmacher A, Boentert M, Young P (2013) Charcot–Marie–Tooth disease: frequency of genetic subtypes in a German neuromuscular center population. Neuromuscul Disord 23(8):647–651
Manganelli F, Tozza S, Pisciotta C, Bellone E, Iodice R, Nolano M et al (2014) Charcot–Marie–Tooth disease: frequency of genetic subtypes in a Southern Italy population. J Peripher Nerv Syst 19(4):292–298
Guzzetta V, Santoro L, Gasparo-Rippa P, Ragno M, Vita G, Caruso G et al (1995) Charcot–Marie–Tooth disease: molecular characterization of patients from central and southern Italy. Clin Genet 47(1):27–32
Morocutti C, Colazza GB, Soldati G, D’Alessio C, Damiano M, Casali C et al (2002) Charcot–Marie–Tooth disease in Molise, a central-southern region of Italy: an epidemiological study. Neuroepidemiology 21(5):241–245
Mostacciuolo ML, Schiavon F, Angelini C, Miccoli B, Piccolo F, Danieli GA (1995) Frequency of duplication at 17p11.2 in families of northeast Italy with Charcot–Marie–Tooth disease type 1. Neuroepidemiology 14(2):49–53
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215
Badano JL, Inoue K, Katsanis N, Lupski JR (2001) New polymorphic short tandem repeats for PCR-based Charcot–Marie–Tooth disease type 1A duplication diagnosis. Clin Chem 47(5):838–843
Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Cianchetti C, Muntoni F (1997) A novel point mutation in the peripheral myelin protein 22 (PMP22) gene associated with Charcot–Marie–Tooth disease type 1A. Neurology 48(2):489–493
Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Cianchetti C, Muntoni F (1998) Charcot–Marie–Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology 50(5):1397–1401
Guernsey DL, Jiang H, Bedard K, Evans SC, Ferguson M, Matsuoka M, et al (2010) Mutation in the gene encoding ubiquitin ligase LRSAM1 in patients with Charcot–Marie–Tooth disease. PLoS Genet. doi:10.1371/journal.pgen.1001081
Engeholm M, Sekler J, Schöndorf DC, Arora V, Schittenhelm J, Biskup S et al (2014) A novel mutation in LRSAM1 causes axonal Charcot–Marie–Tooth disease with dominant inheritance. BMC Neurol 3(14):118
Weterman MA, Sorrentino V, Kasher PR, Jakobs ME, van Engelen BG, Fluiter K et al (2012) A frameshift mutation in LRSAM1 is responsible for a dominant hereditary polyneuropathy. Hum Mol Genet 21(2):358–370
Nicolaou P, Cianchetti C, Minaidou A, Marrosu G, Zamba-Papanicolaou E, Middleton L et al (2013) A novel LRSAM1 mutation is associated with autosomal dominant axonal Charcot–Marie–Tooth disease. Eur J Hum Genet 21(2):190–194
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No conflict of interest exists regarding the present paper.
Additional information
The original version of this article was revised: The author’s given name and family name were initially interchanged inadvertently. The correct names have been corrected above.
An erratum to this article is available at http://dx.doi.org/10.1007/s10072-017-2944-3.
Rights and permissions
About this article
Cite this article
Lorefice, L., Murru, M.R., Coghe, G. et al. Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population. Neurol Sci 38, 1019–1025 (2017). https://doi.org/10.1007/s10072-017-2905-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-017-2905-x